We are delighted to announce the results of our 2024 board elections, marking a significant transition in leadership. As we extend our appreciation to the outgoing board members, we are excited to welcome the newly elected individuals:

• Brooke Molina, PhD – President Elect
• Margaret Sibley, PhD – Secretary
• Betsy Busch, MD – Treasurer
• Stephen Becker, PhD – Board Member
• Alison Pritchard, PhD – Board Member
• J. Faye Dixon, PhD – Board Member
• Douglas Russell, MD – Board Member

A thank you to the outgoing members who have played a pivotal role in shaping APSARD:

• Sam Goldstein, PhD
• Martin Katzman, MD
• Mark Bertin, MD
• Jeffrey Newcorn, MD
• David Goodman, MD
• Beth Krone, PhD

APSARD is thrilled to have a diverse group of experts with a wealth of knowledge and dedication to steering our organization toward continued success in the new year!

The Psychiatric Times has highlighted the 2024 APSARD Annual Conference in a featured article. This piece provides a concise overview of the sessions conducted by APSARD’s Executive Committee Members on the first day, featuring presentations from experts such as Greg Mattingly, M.D., David Goodman, M.D., L.F.A.P.A., Margaret Sibley, Ph.D., Ann Childress, M.D., and Jeff Newcorn, M.D.

Explore the insightful summaries by clicking here.

We, at APSARD, are eagerly anticipating the kick-off of our 2024 conference in Orlando, Florida, on January 18th! This year’s conference promises to be even more exciting and informative than ever before, with a focus on ADHD across special populations, groundbreaking research, and practical tools for clinical practice.

To learn more about what you can expect from the APSARD 2024 conference, be sure to watch this interview with APSARD President-Elect Dr. Gregory W. Mattingly. In this interview, Dr. Mattingly discusses the conference’s highlights, why he’s so excited about this year’s event, and how APSARD is working to improve outcomes for individuals with ADHD.

Watch the interview by clicking the preview.